This Project Grant award of $939,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports research conducted by the University of Notre Dame's Notre Dame Research Division, known as the Office of Research, focused on analyzing the relationship between host obesity and therapeutic response in ovarian cancer. The project aims to advance understanding and treatment of this disease, with an anticipated completion date of August 1, 2027. As the prime grant recipient, the University of Notre Dame will leverage its expertise in areas like engineering, biology, and computer science to carry out this critical biomedical research initiative.